Brief: Cerenis Therapeutics Cash Position And Activity Update For H1 2018

Abionyx Pharma SA

18/07/2018 17:52

July 18 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * CERENIS THERAPEUTICS: CASH POSITION AND ACTIVITY UPDATE
FOR H1
2018 AND KEY PERSPECTIVES FOR THE END OF 2018
    * * SOLID CASH POSITION OF EUR 13.5 MILLION AT JUNE 30, 2018
    * KEY PERSPECTIVES BY END OF 2018: RESULTS OF TANGO PHASE
III
STUDY WITH CER-001 WITH HDL DEFICIENCY PATIENTS
    * BY END OF 2018 EXPECTS PHASE I STUDY OF REPEATED AND
INCREASING
DOSES TO ASSESS CER-209 IN NASH/NAFLD NAFLD/NASH

Source text for Eikon:  ID:nBw7PpvPGa 
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))